Nanomaterials have transformed the field of targeted drug delivery by providing exceptional surface-to-volume ratios, tunable electronic characteristics, and the potential for controlled release mechanisms.
Khudhair et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: